Literature DB >> 8898703

Kinetic evaluation of [11C]dihydrotetrabenazine by dynamic PET: measurement of vesicular monoamine transporter.

R A Koeppe1, K A Frey, T M Vander Borght, A Karlamangla, D M Jewett, L C Lee, M R Kilbourn, D E Kuhl.   

Abstract

(+)-alpha-[11C]Dihydrotetrabenazine (DTBZ) binds to the vesicular monoamine transporter (VMAT2) located in presynaptic vesicles. The purpose of this work was to evaluate various model configurations for analysis of [11C]DTBZ with the aim of providing the optimal measure of monoamine vesicular transporter density obtainable from a single dynamic PET study. PET studies on seven young normal volunteer subjects, ages 20-35, were performed following i.v. injection of 666 +/- 37 MBq (18 +/- 1 mCi) of (+)-alpha-[11C]DTBZ. Dynamic acquisition consisted of a 15-frame sequence over 1 h. Analysis methods included both creation of pixel-by-pixel functional images of transport (K1) and binding (DVtot) and nonlinear least-squares analysis of volume-of-interest data. Pixel-by-pixel calculations were performed for both two-compartment weighted integral calculations and slope-intercept estimations from Logan plots. Nonlinear least-squares analysis was performed applying model configurations with both two-compartments, estimating K1 and DVtot and three compartments, estimating K1-k4. For the more complex configuration, we examined the stability of various binding-related parameters including k3 (konBmax'), k3/k4 (Bmax'/Kd), DVsp[(K1/k2)(k3/k4)], and DVtot [K1/k2(1 + k3/k4)]. The three-compartment model provided significantly improved goodness-of-fit compared to the two-compartment model, yet did not increase the uncertainty in the estimate of the DVtot. Without constraining parameters in the three-compartment model fits, DVtot was found to provide a more stable estimate of binding density than either k3, k3/k4, or DVsp. The two-compartment least-squares analysis yielded approximately 10% underestimations of the total distribution. However, this bias was found to be very consistent from region to region as well as across subjects as indicated by the correlation between two- and three-compartment DVtot estimates of 0.997. We conclude that (+)-alpha-[11C]DTBZ and PET can provide excellent measures of VMAT2 density in the human brain.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8898703     DOI: 10.1097/00004647-199611000-00025

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  15 in total

1.  First demonstration of in vivo mapping for regional brain monoacylglycerol lipase using PET with [11C]SAR127303.

Authors:  Tomoteru Yamasaki; Wakana Mori; Yiding Zhang; Akiko Hatori; Masayuki Fujinaga; Hidekatsu Wakizaka; Yusuke Kurihara; Lu Wang; Nobuki Nengaki; Tomoyuki Ohya; Steven H Liang; Ming-Rong Zhang
Journal:  Neuroimage       Date:  2018-05-05       Impact factor: 6.556

2.  Influx rate of 18F-fluoroaminosuberic acid reflects cystine/glutamate antiporter expression in tumour xenografts.

Authors:  Kathinka E Pitman; Santosh R Alluri; Alexander Kristian; Eva-Katrine Aarnes; Heidi Lyng; Patrick J Riss; Eirik Malinen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-07-01       Impact factor: 9.236

Review 3.  Molecular imaging of β-cells: diabetes and beyond.

Authors:  Weijun Wei; Emily B Ehlerding; Xiaoli Lan; Quan-Yong Luo; Weibo Cai
Journal:  Adv Drug Deliv Rev       Date:  2018-07-03       Impact factor: 15.470

Review 4.  Beta-cell imaging: call for evidence-based and scientific approach.

Authors:  Björn A Blomberg; Ion Codreanu; Gang Cheng; Thomas J Werner; Abass Alavi
Journal:  Mol Imaging Biol       Date:  2013-04       Impact factor: 3.488

5.  Combined insular and striatal dopamine dysfunction are associated with executive deficits in Parkinson's disease with mild cognitive impairment.

Authors:  Leigh Christopher; Connie Marras; Sarah Duff-Canning; Yuko Koshimori; Robert Chen; Isabelle Boileau; Barbara Segura; Oury Monchi; Anthony E Lang; Pablo Rusjan; Sylvain Houle; Antonio P Strafella
Journal:  Brain       Date:  2013-12-12       Impact factor: 13.501

6.  In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers.

Authors:  Rajesh Narendran; Brian J Lopresti; Diana Martinez; Neale Scott Mason; Michael Himes; Maureen A May; Dennis C Daley; Julie C Price; Chester A Mathis; W Gordon Frankle
Journal:  Am J Psychiatry       Date:  2011-10-31       Impact factor: 18.112

7.  Salience network and parahippocampal dopamine dysfunction in memory-impaired Parkinson disease.

Authors:  Leigh Christopher; Sarah Duff-Canning; Yuko Koshimori; Barbara Segura; Isabelle Boileau; Robert Chen; Anthony E Lang; Sylvain Houle; Pablo Rusjan; Antonio P Strafella
Journal:  Ann Neurol       Date:  2014-12-30       Impact factor: 10.422

8.  Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence.

Authors:  Isabelle Boileau; Tina McCluskey; Junchao Tong; Yoshiaki Furukawa; Sylvain Houle; Stephen J Kish
Journal:  Neuropsychopharmacology       Date:  2015-08-31       Impact factor: 7.853

9.  Validation of midbrain positron emission tomography measures for nigrostriatal neurons in macaques.

Authors:  Christopher A Brown; Morvarid K Karimi; LinLin Tian; Hugh Flores; Yi Su; Samer D Tabbal; Susan K Loftin; Stephen M Moerlein; Joel S Perlmutter
Journal:  Ann Neurol       Date:  2013-09-16       Impact factor: 10.422

10.  11C-dihydrotetrabenazine PET of the pancreas in subjects with long-standing type 1 diabetes and in healthy controls.

Authors:  Robin Goland; Matthew Freeby; Ramin Parsey; Yoshifumi Saisho; Dileep Kumar; Norman Simpson; Joy Hirsch; Martin Prince; Antonella Maffei; J John Mann; Peter C Butler; Ronald Van Heertum; Rudolph L Leibel; Masanori Ichise; Paul E Harris
Journal:  J Nucl Med       Date:  2009-02-17       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.